Rearrangements of Chromosome Band 3q21 in Myeloid Leukemia
- 1 January 2002
- journal article
- review article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 43 (1) , 59-66
- https://doi.org/10.1080/10428190210196
Abstract
Chromosome rearrangements affecting band 3q21, namely, the inv(3)(q21q26), the t(3;3)(q21;q26), and the t(1;3)(p36;q21), are associated with a particularly poor prognosis in myeloid leukemia or myelodysplasia. Originally, inv(3) and t(3;3) breakpoints have been reported to cluster in a region (breakpoint cluster region, BCR) of approximately 30 kb, which is located centromeric and downstream of the ribophorin I (RPN-I) gene. More recently, we established a PAC contig that includes the 3q21 BCR, and used these PAC clones to map breakpoints in patient samples by both metaphase and interphase fluorescence in situ hybridization (FISH) analysis. A significant proportion of inv(3) and t(3;3) breakpoints was located at sometimes considerable distances centromeric of the originally described BCR, in a region recently also implicated in t(1;3) rearrangements. These breakpoints may thus define a second, centromeric BCR (BCR-C), or extend the original 3q21 BCR to a size of approximately 100 kb. Activation of the EVI-1 gene in 3q26 by regulatory sequences of the housekeeping gene RPN-I has been suggested as a leukemogenic mechanism in patients with inv(3) and t(3;3). However, despite a number of characteristics that make EVI-1 an attractive candidate oncogene, its biological properties fail to fully explain the phenotype of leukemias carrying 3q rearrangements. Several additional candidate genes have been identified in or near the 3q21 breakpoint region, but their possible contribution to the characteristics of leukemias with 3q21 rearrangements remains to be explored.Keywords
This publication has 45 references indexed in Scilit:
- Transcription Factor GATA-2 Gene Is Located Near 3q21 Breakpoints in Myeloid LeukemiaBiochemical and Biophysical Research Communications, 2000
- MDS1/EVI1 enhances TGF-β1 signaling and strengthens its growth-inhibitory effect, but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-β1Leukemia, 1999
- Evi-1 ZF1 DNA binding activity and a second distinct transcriptional repressor region are both required for optimal transformation of Rat1 fibroblastsOncogene, 1998
- The SCL/TAL1 gene: Roles in normal and malignant haematopoiesisBioEssays, 1997
- Rapid induction of B-cell lymphomas in mice carrying a human IgH/c-mycYACOncogene, 1997
- The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivatorLeukemia, 1997
- The Evi-1 proto-oncogene encodes a transcriptional repressor activity associated with transformationOncogene, 1997
- Expression of the Zn finger gene, EVI-1, in acute promyelocytic leukemiaLeukemia, 1997
- Pattern of Expression and Their Clinical Implications of the GATA Family, Stem Cell Leukemia Gene, and EVI1 in Leukemia and Myelodysplastic SyndromesLeukemia & Lymphoma, 1996
- Cloning of breakpoints in 3q21 associated with hematologic malignancyCancer Genetics and Cytogenetics, 1995